Jomaa; Hassan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jomaa; Hassan.The latest application filed is for "combination preparations of 3-n-formyl hydroxy amino propyl phosphonic acid derivatives or 3-n-acetyl hydroxy amino propyl phosphonic acid derivatives together with special pharmaceutical active ingredients".

Company Profile

0.9.17

Jomaa; Hassan - Giessen DE
Jomaa, Hassan - GieBen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination Preparations Of 3-n-formyl Hydroxy Amino Propyl Phosphonic Acid Derivatives Or 3-n-acetyl Hydroxy Amino Propyl Phosphonic Acid Derivatives Together With Special Pharmaceutical Active Ingredients App 20150190418 - Jomaa; Hassan ; et al.	2015-07-09
Use Of Organophosphorus Compounds For The Therapeutic And Prophylactic Treatment Of Infections App 20110306578 - Jomaa; Hassan	2011-12-15
Inactivation Of Genes Of The Mep Pathway App 20110129883 - JOMAA; HASSAN ; et al.	2011-06-02
Organophosphorous Compounds for the Activation of Gamma/Delta T Cells App 20110112054 - Jomaa; Hassan ; et al.	2011-05-12
Inactivation of genes of the MEP pathway Grant 7,875,279 - Jomaa , et al. January 25, 2	2011-01-25
Organophosphorous compounds for the activation of gamma/delta T cells Grant 7,871,992 - Jomaa , et al. January 18, 2	2011-01-18
Organophosphoric derivatives useful as anti-parasitic agents Grant 7,638,505 - Van Calenbergh , et al. December 29, 2	2009-12-29
Organophosphoric Derivatives Useful as Anti-Parasitic Agents App 20080312190 - Van Calenbergh; Serge ; et al.	2008-12-18
Organophosphorous Compounds for the Activation of Gamma/Delta T Cells App 20080249067 - Jomaa; Hassan ; et al.	2008-10-09
Inactivation Of Genes Of The Mep Pathway App 20080206267 - Jomaa; Hassan ; et al.	2008-08-28
Organo-phosphorous compounds for activating gamma/delta T cells Grant 7,399,756 - Jomaa , et al. July 15, 2	2008-07-15
Medicaments containing bisphosphonic acids and derivatives thereof for preventing and treating diseases and allergies App 20060040899 - Jomaa; Hassan	2006-02-23
Organo-phosphorous compounds for activating gamma/delta t cells App 20060030546 - Jomaa; Hassan ; et al.	2006-02-09
Phosphorous organic compounds and their use App 20050075511 - Jomaa, Hassan	2005-04-07
Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined with specific pharmaceutical active agents App 20040235784 - Jomaa, Hassan ; et al.	2004-11-25
Phosphorous organic compounds and their use Grant 6,812,224 - Jomaa November 2, 2	2004-11-02
Phosphorous organic compounds and their use Grant 6,753,324 - Jomaa June 22, 2	2004-06-22
Use of organophosphorus compounds for the therapeutic and prophylactic treatment of infections App 20040082549 - Jomaa, Hassan	2004-04-29
Use of bisphosphonates for the prevention and treatment of infectious processes Grant 6,696,427 - Jomaa February 24, 2	2004-02-24
Use of compounds comprising a nitrogen-oxygen heterocycle App 20040033994 - Jomaa, Hassan	2004-02-19
Use of compounds with a nitrogen-oxygen heterocycle Grant 6,638,957 - Jomaa October 28, 2	2003-10-28
Genes of the 1-desoxy -d-xylulose biosynthesis path App 20030115634 - Jomaa, Hassan	2003-06-19
Organophosphorus compounds and the use thereof Grant 6,534,489 - Jomaa March 18, 2	2003-03-18
Phosphorous organic compounds and their use App 20030045746 - Jomaa, Hassan	2003-03-06
Use of 2-phenylene diamine derivatives for the treatment of infections App 20030036532 - Jomaa, Hassan ; et al.	2003-02-20
Phosphorous organic compounds and their use App 20030036533 - Jomaa, Hassan	2003-02-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.